Alnylam’s Nov 2026 filings reveal modest institutional gains and routine director purchases—no control shifts, just continued SEC‑compliant transparency.
Liberty All‑Star Equity Fund cuts Boston Scientific, adds GE HealthCare and Keurig Dr Pepper – uncovering its IT focus, digital‑health pivot and cautious approach to regulatory risk.
Roche’s Gazyva/Gazyvaro offers the first glycoengineered anti‑CD20 therapy for SLE, showing significant disease‑activity reduction and a promising cost‑effectiveness profile that could reshape lupus treatment and reimbursement models across Europe.
Insightful Cencora 13 Nov 2026 insider equity moves: CEO and executives receive $12.4 M RSUs vesting 2027‑2029 and share purchases, boosting alignment and investor confidence.